Analysis of Kazakhstan pharmaceutical market of drugs used in paradontopathy

Aliya S. Mamatova, Z. V. Sakipova, R. V. Aiupova, G. S. Serikova

2016

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.24959/uekj.16.28
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This article presents the results of a study of the pharmaceutical market of Kazakhstan, Russia, Ukraine, here is studied the range of drugs used in parodontopathy. Analyzed the structure of market, in accordance with the groups of drugs (ATC-classification), dosage form, composition of the active ingredients.Particular attention in this segment of drugs is given to Kazakhstan pharmaceutical market. Studied the structure of manufacturing countries (Kazakh manufacturers hold only 13% of the market), highlighted the possibilities and directions of development of the domestic pharmaceutical industry in this segment.